Drug Approvals

Dupixent Becomes First Biologic Approved for Chronic Spontaneous Urticaria in Children Ages 2-11

2 min

Dupixent Becomes First Biologic Approved for Children Ages 2-11 with Chronic Spontaneous Urticaria

2 min

FDA Approval Elarekig: What You Need to Know About TRD Treatment

FDA · treatment-resistant depression · 10 min

Denali Therapeutics Receives FDA Approval for Avlayah (Tividenofusp Alfa) to Treat Hunter Syndrome

Hunter syndrome (MPS II) · 3 min

FDA Extends Sanofi Sarclisa Subcutaneous Review by Three Months for Multiple Myeloma Treatment

2 min

NRx Pharmaceuticals Receives Positive FDA Feedback on Preservative-Free Ketamine Generic Drug Application

FDA · 3 min

Lupin Launches Generic Dapagliflozin-Metformin XR Tablets in US as Xigduo XR Alternative

2 min

Sanofi's Tzield Approved by FDA for Children as Young as 1 Year to Delay Type 1 Diabetes Progression

Type 1 Diabetes · 3 min

Generic Drug Forum: Key Takeaways for US Market Access

general · 12 min

THMA CPE Circle 2026: Pharma Exec Networking Focus

general · 3 min

FDA Approves Merck's IDVYNSO: First Non-INSTI, Tenofovir-Free Two-Drug HIV Treatment

FDA · HIV Treatment · 3 min

FDA Approval of Viruxa: Market Analysis and Clinical Review for Advanced Melanoma

FDA · Advanced Melanoma · 8 min